Contract drug manufacturer Catalent Inc. expands its U.S. production of the Covid-19 vaccine from Moderna Inc., a development that could ensure the U.S. has ample supply as it increases vaccinations.
Catalent has reached an agreement with Moderna that increases the rate of vaccine output at the contract manufacturer’s factory in Bloomington, Ind., This month to approx. 400 vials per minute, according to people familiar with the matter.
Catalent shifts the production of the shot to a faster production line from two slower ones. New doses will be ready for shipping from next month, people said, and the upgraded plant will be able to fill an additional 80 million vials a year.
The expansion will help Moderna achieve its goal of delivering an additional 1
Production in the United States of several approved vaccines has increased in recent weeks as manufacturers have scaled up production lines and taken other steps to increase production.